We Care™: Raising Awareness and Promoting Safety in Diabetes Management
Diabetes is considered a widespread health challenge affecting millions of people globally, regardless of their background or socioeconomic status. Currently, an estimated 371 million people worldwide have diabetes, and this number is expected to rise to 550 million by 2030.
In light of these statistics, the We Care™ program addresses crucial issues related to diabetes management, focusing on information dissemination and preventive measures. This comprehensive initiative, developed by HTL-STREFA S.A., the world’s largest medical device company specializing in safe lancets, personal lancets, and insulin injection needles, provides valuable tools and resources for both healthcare professionals and patients.
We Care™ comprises a series of coordinated activities designed to build awareness through the use of safe medical devices in diabetes treatment. The program’s powerful tagline, “Prevention, Diagnosis, Treatment,” perfectly encapsulates its core objectives.
Previously, the communication materials, while informative, lacked a unified visual identity. This ultimately hindered their ability to effectively convey the program’s message. Our challenge was to create a distinct visual identity that would serve as a showcase for the We Care™ initiative and clearly differentiate it from the company’s product portfolio.
